A model of Costeff Syndrome reveals metabolic and protective functions of mitochondrial OPA3
- 1 August 2010
- journal article
- Published by The Company of Biologists in Development
- Vol. 137 (15), 2587-2596
- https://doi.org/10.1242/dev.043745
Abstract
Costeff Syndrome, which is caused by mutations in the OPTIC ATROPHY 3 (OPA3) gene, is an early-onset syndrome characterized by urinary excretion of 3-methylglutaconic acid (MGC), optic atrophy and movement disorders, including ataxia and extrapyramidal dysfunction. The OPA3 protein is enriched in the inner mitochondrial membrane and has mitochondrial targeting signals, but a requirement for mitochondrial localization has not been demonstrated. We find zebrafish opa3 mRNA to be expressed in the optic nerve and retinal layers, the counterparts of which in humans have high mitochondrial activity. Transcripts of zebrafish opa3 are also expressed in the embryonic brain, inner ear, heart, liver, intestine and swim bladder. We isolated a zebrafish opa3 null allele for which homozygous mutants display increased MGC levels, optic nerve deficits, ataxia and an extrapyramidal movement disorder. This correspondence of metabolic, ophthalmologic and movement abnormalities between humans and zebrafish demonstrates a phylogenetic conservation of OPA3 function. We also find that delivery of exogenous Opa3 can reduce increased MGC levels in opa3 mutants, and this reduction requires the mitochondrial localization signals of Opa3. By manipulating MGC precursor availability, we infer that elevated MGC in opa3 mutants derives from extra-mitochondrial HMG-CoA through a non-canonical pathway. The opa3 mutants have normal mitochondrial oxidative phosphorylation profiles, but are nonetheless sensitive to inhibitors of the electron transport chain, which supports clinical recommendations that individuals with Costeff Syndrome avoid mitochondria-damaging agents. In summary, this paper introduces a faithful Costeff Syndrome model and demonstrates a requirement for mitochondrial OPA3 to limit HMG-CoA-derived MGC and protect the electron transport chain against inhibitory compounds.Keywords
This publication has 38 references indexed in Scilit:
- OPA3, mutated in 3-methylglutaconic aciduria type III, encodes two transcripts targeted primarily to mitochondriaMolecular Genetics and Metabolism, 2010
- Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's diseaseProceedings of the National Academy of Sciences of the United States of America, 2009
- Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novelOPA1mutationsHuman Mutation, 2009
- Costeff optic atrophy syndrome: New clinical case and novel molecular findingsJournal of Inherited Metabolic Disease, 2008
- Using retroviruses as a mutagenesis tool to explore the zebrafish genomeBriefings in Functional Genomics and Proteomics, 2008
- A Zebrafish Model of Human Barth Syndrome Reveals the Essential Role of Tafazzin in Cardiac Development and FunctionCirculation Research, 2006
- IEM Digest for JanuaryMolecular Genetics and Metabolism, 2005
- Proteomic Analysis of the Mouse Liver Mitochondrial Inner MembraneJournal of Biological Chemistry, 2003
- Stages of embryonic development of the zebrafishDevelopmental Dynamics, 1995
- Multiple syndromes of 3-methylglutaconic aciduriaPediatric Neurology, 1993